Author: HealthJustfine Team

Hormonal health is now widely described as one of the fastest-growing verticals in femtech – in Europe, arguably the fastest-growing one.The clearest expression of that momentum is the race toward continuous hormone monitoring, which we’ve covered in depth on Femtech Insider: Level Zero Health raised $6.9 million for its DNA-based biosensors, and in June, Clair Health raised an $11.6 million seed…

Read More

ResMed Inc. (NYSE:RMD) is one of the most undervalued large cap stocks to buy according to analysts. On June 1, ResMed finalized its acquisition of Noctrix Health, a medical device company known for developing non-pharmacologic wearable therapeutics. This strategic move expands ResMed’s clinical sleep health portfolio into the treatment of Restless Legs Syndrome/RLS, which is…

Read More